Stephen L Atkin

InstitutionWeill Cornell Medicine Qatar
AddressDoha
Qatar
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 21 Covid-19 publications, with a maximum of 5 publications in March 2021
    All Publications
    Bar chart showing 187 publications over 20 distinct years, with a maximum of 34 publications in 2018
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Moin ASM, Al-Qaissi A, Sathyapalan T, Atkin SL, Butler AE. Type 2 Diabetes Coagulopathy Proteins May Conflict With Biomarkers Reflective of COVID-19 Severity. Front Endocrinol (Lausanne). 2021; 12:658304. PMID: 34248840.
      Citations:    Translation:Humans
    2. Moin ASM, Al-Qaissi A, Sathyapalan T, Atkin SL, Butler AE. Soluble Neuropilin-1 Response to Hypoglycemia in Type 2 Diabetes: Increased Risk or Protection in SARS-CoV-2 Infection? Front Endocrinol (Lausanne). 2021; 12:665134. PMID: 34248841.
      Citations:    Translation:Humans
    3. AlQahtani M, Abdulrahman A, Almadani A, Alali SY, Al Zamrooni AM, Hejab AH, Conroy RM, Wasif P, Otoom S, Atkin SL, Abduljalil M. Randomized controlled trial of convalescent plasma therapy against standard therapy in patients with severe COVID-19 disease. Sci Rep. 2021 05 11; 11(1):9927. PMID: 33976287.
      Citations: 21     Fields:    Translation:Humans
    4. Moin ASM, Al-Qaissi A, Sathyapalan T, Atkin SL, Butler AE. Platelet Protein-Related Abnormalities in Response to Acute Hypoglycemia in Type 2 Diabetes. Front Endocrinol (Lausanne). 2021; 12:651009. PMID: 33859620.
      Citations: 1     Translation:HumansCells
    5. Kumar N, AbdulRahman A, AlAli S, Otoom S, Atkin SL, AlQahtani M. Time Till Viral Clearance of Severe Acute Respiratory Syndrome Coronavirus 2 Is Similar for Asymptomatic and Non-critically Symptomatic Individuals. Front Med (Lausanne). 2021; 8:616927. PMID: 33842498.
      Citations:    
    6. Moin ASM, Sathyapalan T, Diboun I, Atkin SL, Butler AE. Identification of macrophage activation-related biomarkers in obese type 2 diabetes that may be indicative of enhanced respiratory risk in COVID-19. Sci Rep. 2021 03 19; 11(1):6428. PMID: 33742062.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    7. Moin ASM, Sathyapalan T, Atkin SL, Butler AE. Correction to: COVID-19 biomarkers for severity mapped to polycystic ovary syndrome. J Transl Med. 2021 Mar 15; 19(1):106. PMID: 33722238.
      Citations:    Fields:    
    8. Almadhi MA, Abdulrahman A, Alawadhi A, Rabaan AA, Atkin S, AlQahtani M. The effect of ABO blood group and antibody class on the risk of COVID-19 infection and severity of clinical outcomes. Sci Rep. 2021 03 11; 11(1):5745. PMID: 33707451.
      Citations: 6     Fields:    Translation:Humans
    9. Almadhi MA, Abdulrahman A, Sharaf SA, AlSaad D, Stevenson NJ, Atkin SL, AlQahtani MM. The high prevalence of asymptomatic SARS-CoV-2 infection reveals the silent spread of COVID-19. Int J Infect Dis. 2021 Apr; 105:656-661. PMID: 33647516.
      Citations: 9     Fields:    Translation:HumansPHPublic Health
    10. Moin ASM, Sathyapalan T, Butler AE, Atkin SL. Vitamin D Association With Macrophage-Derived Cytokines in Polycystic Ovary Syndrome: An Enhanced Risk of COVID-19 Infection? Front Endocrinol (Lausanne). 2021; 12:638621. PMID: 33716989.
      Citations: 1     Translation:HumansCells
    11. Moin ASM, Nandakumar M, Sathyapalan T, Atkin SL, Butler AE. Biomarkers of COVID-19 severity may not serve patients with polycystic ovary syndrome. J Transl Med. 2021 02 11; 19(1):63. PMID: 33573655.
      Citations:    Fields:    Translation:Humans
    12. Moin ASM, Sathyapalan T, Atkin SL, Butler AE. The relationship of soluble neuropilin-1 to severe COVID-19 risk factors in polycystic ovary syndrome. Metabol Open. 2021 Mar; 9:100079. PMID: 33521617.
      Citations: 2     
    13. Abdulrahman A, AlSabbagh M, AlAwadhi A, Al-Tawfiq JA, Rabaan AA, Atkin S, AlQahtani M. Quarantining arriving travelers in the era of COVID-19: balancing the risk and benefits a learning experience from Bahrain. Trop Dis Travel Med Vaccines. 2021 Jan 12; 7(1):1. PMID: 33436085.
      Citations: 2     
    14. Moin ASM, Sathyapalan T, Atkin SL, Butler AE. COVID-19 biomarkers for severity mapped to polycystic ovary syndrome. J Transl Med. 2020 12 22; 18(1):490. PMID: 33353554.
      Citations: 3     Fields:    
    15. Moin ASM, Al-Qaissi A, Sathyapalan T, Atkin SL, Butler AE. Mapping of type 2 diabetes proteins to COVID-19 biomarkers: A proteomic analysis. Metabol Open. 2021 Mar; 9:100074. PMID: 33364597.
      Citations: 1     
    16. Moin ASM, Al-Qaissi A, Sathyapalan T, Atkin SL, Butler AE. Do biomarkers of COVID-19 severity simply reflect a stress response in type 2 diabetes: Biomarker response to hypoglycemia. Metabolism. 2021 01; 114:154417. PMID: 33157081.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    17. Al-Qahtani M, AlAli S, AbdulRahman A, Salman Alsayyad A, Otoom S, Atkin SL. The prevalence of asymptomatic and symptomatic COVID-19 in a cohort of quarantined subjects. Int J Infect Dis. 2021 Jan; 102:285-288. PMID: 33157290.
      Citations: 10     Fields:    Translation:HumansPHPublic Health
    18. AbdulRahman A, AlAli S, Yaghi O, Shabaan M, Otoom S, Atkin SL, AlQahtani M. COVID-19 and sickle cell disease in Bahrain. Int J Infect Dis. 2020 Dec; 101:14-16. PMID: 32980556.
      Citations: 5     Fields:    Translation:HumansPHPublic Health
    19. Ali KF, Whitebridge S, Jamal MH, Alsafy M, Atkin SL. Perceptions, Knowledge, and Behaviors Related to COVID-19 Among Social Media Users: Cross-Sectional Study. J Med Internet Res. 2020 09 08; 22(9):e19913. PMID: 32841153.
      Citations: 17     Fields:    Translation:HumansPHPublic Health
    20. Moin ASM, Sathyapalan T, Atkin SL, Butler AE. Renin-Angiotensin System overactivation in polycystic ovary syndrome, a risk for SARS-CoV-2 infection? Metabol Open. 2020 Sep; 7:100052. PMID: 32838280.
      Citations: 5     
    21. Moin ASM, Al-Qaissi A, Sathyapalan T, Atkin SL, Butler AE. Renin-Angiotensin System Overactivation in Type 2 Diabetes: A Risk for SARS-CoV-2 Infection? Diabetes Care. 2020 10; 43(10):e131-e133. PMID: 32616611.
      Citations: 3     Fields:    
    Atkin's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (331)
    Explore
    _
    Co-Authors (43)
    Explore
    _
    Similar People (60)
    Explore
    _